Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Norina Tanaka, MD PhD, Aya Watanabe, MD, Suguru Honda, MD, Mitsuko Kobayashi, Yan-Hua Wang, MD, Yuki Iizuka, MD, Michiko Ryuzaki, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Katsunori Ikari, MD PhD, Masayuki Shiseki, MD PhD, Masayoshi Harigai, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 5219.

https://doi.org/10.1182/blood-2019-127836

Published: 2019

Journal Articles

Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor

Shoko Oshima, MD, Akihito Shinohara, MD, Hideki Ishida, MD PhD, Miki Umeda, MD, Satoko Osanai, MD, Satoru Itoi, MD, Michiko Ryuzaki, MD, Yuki Izuka, MD, Aya Watanabe, MD, Norina Tanaka, MD PhD, Midori Ishiyama, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Shotaro Hagiwara, MD PhD, Masayuki Shiseki, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 2910.

https://doi.org/10.1182/blood-2019-125601

Published: 2019

Journal Articles

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

Shotaro Hagiwara, MD PhD, Yan-Hua Wang, MD, Hirohito Kobayashi, MD, Yutaka Kato, MD, Norina Tanaka, MD PhD, Yuki Iizuka, MD, Aya Watanabe, MD, Midori Ishiyama, MD PhD, Akihito Shinohara, MD PhD, Hiroshi Kazama, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD PhD, Hitoshi Kanno, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 3133.

https://doi.org/10.1182/blood-2019-127739

Published: 2019

Journal Articles

The Analysis of HIV-Associated Lymphoma in Japan

Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD, Junji Tanaka, MD PhD, Seiji Okada, MD PhD

Blood (2018) 132 (Supplement 1): 5315.

https://doi.org/10.1182/blood-2018-99-114060

Published: 2018

Journal Articles

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Blood (2018) 132 (Supplement 1): 5320.

https://doi.org/10.1182/blood-2018-99-111649

Published: 2018

Journal Articles

Phenotypic Analysis of NK Cell in Multiple Myeloma Patients

Shotaro Hagiwara, MDPhD, Noriko Sorimachi, PhD, Junji Tanaka, MD PhD

Blood (2017) 130 (Supplement 1): 5384.

https://doi.org/10.1182/blood.V130.Suppl_1.5384.5384

Published: 2017

Journal Articles

Early Increased Platelet Count Is a Predictive Factor for a Long-Term Response in High-Dose Dexamethasone Treatment for Newly-Diagnosed Immune Thrombocytopenia Patients.

Midori Ishiyama, MD PhD, Masayuki Shiseki, MD, Shotaro Hagiwara, MDPhD, Kentaro Yoshinaga, MD, Junji Tanaka, MD PhD

Blood (2017) 130 (Supplement 1): 1050.

https://doi.org/10.1182/blood.V130.Suppl_1.1050.1050

Published: 2017

Journal Articles

The Effect and the Cost of Tandem Transplantation in Multiple Myeloma Patients with Adverse Cytogenetics

Masato Komuro, Naoki Kondo, Shotaro Hagiwara, MDPhD, Takeshi Kuwahara, Junji Tanaka, MD PhD

Blood (2017) 130 (Supplement 1): 5608.

https://doi.org/10.1182/blood.V130.Suppl_1.5608.5608

Published: 2017

Journal Articles

Prospective Clinical Study of High Dose Chemotherapy Followed By Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory HIV-Associated Lymphoma

Shotaro Hagiwara, MDPhD, Tomoko Uehira, Hirokazu Nagai, MD PhD, Seiji Okada, MD, PhD, Junko Tanuma, Akiko Moriya Saito, MD PhD

Blood (2017) 130 (Supplement 1): 5214.

https://doi.org/10.1182/blood.V130.Suppl_1.5214.5214

Published: 2017

Journal Articles

Central Nervous System Invasion in Multiple Myeloma: A Nationwide Survey of 75 Patients in Japan

Blood (2016) 128 (22): 4493.

https://doi.org/10.1182/blood.V128.22.4493.4493

Published: 2016

Journal Articles

Correlation Between Prognosis and Morphological Abnormalities in Multiple Myeloma

Shun Iida, MD BSPharm, Yoshihiko Ueda, MD, PhD, Shotaro Hagiwara, MD, Grad Dip Clin Epid., PhD

Blood (2016) 128 (22): 5634.

https://doi.org/10.1182/blood.V128.22.5634.5634

Published: 2016

Journal Articles

High Expression of AF1q Is an Adverse Prognostic Factor in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation

Shotaro Hagiwara, Ana-Iris Schiefer, MD, Sohtaro MINE, MD BPharm, BA, Lukas Kenner, MD, PhD, William Tse, MD FACP

Blood (2015) 126 (23): 5321.

https://doi.org/10.1182/blood.V126.23.5321.5321

Published: 2015

Journal Articles

Clinicopathological Analysis of CNS Involvement in Multiple Myeloma

Tomiteru Togano, MDPhD, Sohtaro MINE, MD BPharm, BA, Akiyoshi Miwa, MD PhD, Shotaro Hagiwara

Blood (2015) 126 (23): 5326.

https://doi.org/10.1182/blood.V126.23.5326.5326

Published: 2015

Journal Articles

MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan

Shotaro Hagiwara, Shinichiro Okamoto, Kosei Matsue, Shinsuke Iida, Kazutaka Sunami, Takuya Komeno, Kenshi Suzuki, Kiyoshi Ando, Masafumi Taniwaki, Kensei Tobinai, MD PhD, Takaaki Chou, Hitomi Kaneko, Hiromi Iwasaki, MD PhD, Chie Uemura, Hiromi Tamakoshi, Mohamed H Zaki, Thomas Doerr, Yoshiaki Kuroda, Tatsuo Ichinohe, MDPhD

Blood (2015) 126 (23): 5374.

https://doi.org/10.1182/blood.V126.23.5374.5374

Published: 2015

Journal Articles

Extent of Myeloma Cast-Nephropathy Correlates Well with Serum Creatinine: Findings from Autopsied Cases

Junichiro Takano, MD, Sohtaro MINE, MD BPharm, BA, Shotaro Hagiwara, MD PhD, Akiyoshi Miwa, MD PhD

Blood (2014) 124 (21): 5700.

https://doi.org/10.1182/blood.V124.21.5700.5700

Published: 2014

Journal Articles

Multiple Elements Classified Hematological Malignancies from Healthy Population

Shotaro Hagiwara, MD PhD, Yoshinari Suzuki, Akihiro Nakayama, Akihiro Matsunaga, Yutaka Iida, Mari Shimura

Blood (2014) 124 (21): 5959.

https://doi.org/10.1182/blood.V124.21.5959.5959

Published: 2014

Journal Articles

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

Masataka Takeshita, MD PhD, Risen Hirai, MD, Akira Tanimura, MD, Miki Nakamura, MD PhD, Shotaro Hagiwara, MD PhD, Akiyoshi Miwa, MD PhD

Blood (2014) 124 (21): 5837.

https://doi.org/10.1182/blood.V124.21.5837.5837

Published: 2014

Journal Articles

Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Shuji Ozaki, Hiroshi Handa, MD PhD, Takayuki Saitoh, MD, PhD, Hirokazu Murakami, MD, PhD, Mitsuhiro Itagaki, MD, Hideki Asaoku, MD, Kenshi Suzuki, MD PhD, Atsushi Isoda, MD PhD, Morio Sawamura, MD PhD, Jun Konishi, MD, Kazutaka Sunami, Naoki Takezako, MD PhD, Shotaro Hagiwara, MD PhD, Yoshiaki Kuroda, MD PhD, Takaaki Chou, Eiko Shibata, Kazuyuki Shimizu, MD, Eiichi Nagura, MD

Blood (2014) 124 (21): 5684.

https://doi.org/10.1182/blood.V124.21.5684.5684

Published: 2014

Journal Articles

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Miki Nakamura, MD, PhD, Akira Tanimura, MD, Masataka Takeshita, MD, PhD, Akiyoshi Miwa, MD, PhD

Blood (2013) 122 (21): 2171.

https://doi.org/10.1182/blood.V122.21.2171.2171

Published: 2013

Journal Articles

‘in Vivo Labelling Index System' in Myelomology Using an Innovative Thio-Thymidine PET/CT Combined with Amino-Acid PET/CT with Higher Visualizing Efficiency Than Conventional FDG PET/CT. - SUVmax by Thio-Thymidine PET/CT which Can Detect DNA-Synthesizing Myeloma Cell Nests in Vivo, Strongly Correlated with FISH Abnormalities in 74 Plasma Cell Dyscrasia Patients

Akiyoshi Miwa, MD, PhD, Shotaro Hagiwara, MD, PhD, Risen Hirai, MD, Kazuo Kubota, MD, PhD, Momoko Okazaki, MD

Blood (2013) 122 (21): 1858.

https://doi.org/10.1182/blood.V122.21.1858.1858

Published: 2013

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Clinical Significance of KIR Genotype in Patients with Methotrexate-Associated Lymphoproliferative Disorders

Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor

Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress

The Analysis of HIV-Associated Lymphoma in Japan

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Phenotypic Analysis of NK Cell in Multiple Myeloma Patients

Early Increased Platelet Count Is a Predictive Factor for a Long-Term Response in High-Dose Dexamethasone Treatment for Newly-Diagnosed Immune Thrombocytopenia Patients.

The Effect and the Cost of Tandem Transplantation in Multiple Myeloma Patients with Adverse Cytogenetics

Prospective Clinical Study of High Dose Chemotherapy Followed By Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory HIV-Associated Lymphoma

Central Nervous System Invasion in Multiple Myeloma: A Nationwide Survey of 75 Patients in Japan

Correlation Between Prognosis and Morphological Abnormalities in Multiple Myeloma

High Expression of AF1q Is an Adverse Prognostic Factor in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation

Clinicopathological Analysis of CNS Involvement in Multiple Myeloma

MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan

Extent of Myeloma Cast-Nephropathy Correlates Well with Serum Creatinine: Findings from Autopsied Cases

Multiple Elements Classified Hematological Malignancies from Healthy Population

Application of Hematopoietic Progenitor Cell Count: To Optimize Peripheral Blood Stem Cell Harvest

Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only